Coordinatore | RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
Organization address
address: SEMINARSTRASSE 2 contact info |
Nazionalità Coordinatore | Germany [DE] |
Sito del progetto | http://www.europeanstrokenetwork.eu |
Totale costo | 13˙005˙201 € |
EC contributo | 9˙953˙915 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2007-A |
Funding Scheme | CP-IP |
Anno di inizio | 2008 |
Periodo (anno-mese-giorno) | 2008-03-01 - 2013-08-31 |
# | ||||
---|---|---|---|---|
1 |
RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
Organization address
address: SEMINARSTRASSE 2 contact info |
DE (HEIDELBERG) | coordinator | 0.00 |
2 |
Nome Ente NON disponibile
Organization address
address: STENBACKINKATU 9 contact info |
FI (HELSINKI) | participant | 0.00 |
3 |
BOEHRINGER INGELHEIM INTERNATIONALGMBH
Organization address
address: BINGER STRASSE contact info |
DE (INGELHEIM) | participant | 0.00 |
4 |
CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Organization address
address: Chariteplatz 1 contact info |
DE (BERLIN) | participant | 0.00 |
5 |
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
Organization address
address: "Via Adamello, 16" contact info |
IT (MILAN) | participant | 0.00 |
6 |
INSTITUT CATALA DE LA SALUT
Organization address
address: GRAN VIA DE LES CORTS CATALANES 587 contact info |
ES (BARCELONA) | participant | 0.00 |
7 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
FR (PARIS) | participant | 0.00 |
8 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | participant | 0.00 |
9 |
SOLVO BIOTECHNOLOGY RT
Organization address
address: Kozep fasor contact info |
HU (Szeged) | participant | 0.00 |
10 |
STITELSEN SITS INTERNATIONAL
Organization address
address: KAROLINSKA SJUKHUSET STROKEFORSKNINGSENHETEN R2 3 contact info |
SE (STOCKHOLM) | participant | 0.00 |
11 |
STROKE ALLIANCE FOR EUROPE
Organization address
address: RUE WASHINGTON 40 contact info |
BE (BRUSSELS) | participant | 0.00 |
12 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Organization address
address: The Old Schools, Trinity Lane contact info |
UK (CAMBRIDGE) | participant | 0.00 |
13 |
UNIVERSITAET BERN
Organization address
address: Hochschulstrasse 4 contact info |
CH (BERN) | participant | 0.00 |
14 |
UNIVERSITAET DES SAARLANDES
Organization address
address: CAMPUS contact info |
DE (SAARBRUECKEN) | participant | 0.00 |
15 |
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Organization address
address: HEIDELBERGLAAN 100 contact info |
NL (UTRECHT) | participant | 0.00 |
16 |
UNIVERSITE D'ARTOIS
Organization address
address: RUE DU TEMPLE 9 contact info |
FR (ARRAS) | participant | 0.00 |
17 |
WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
Organization address
address: SCHLOSSPLATZ 2 contact info |
DE (MUENSTER) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'The European Stroke Research Network (EUSTROKE) will be a collaborative effort that brings together researchers, government, industry, the non-profit sector and patient group associations. This network will put Europe at the forefront of stroke research through its multi-disciplinary research program, high-quality training for European scientists and clinicians, and national and global partnerships. A primary focus of the EUSTROKE research programme is to improve our understanding of the neurovascular unit to enable better prevention and treatment of stroke. This involves elucidation of dynamic interactions of vascular, cellular and matrix signalling in both the grey and white matter of the brain. Our research strategy looks beyond the single cell for a more integrative answer to ischemic brain damage. The goals of EUSTROKE will be addressed by a wide variety of multidisciplinary European research teams working on various aspects of the neurovascular unit. Thus EUSTROKE will promote integration of both clinical and experimental research teams in cerebrovascular biology, imaging, prevention, and reperfusion with a common focus upon the NVU. The project will aim at developing new approaches for targeting the NVU to improve potential combination or multi-targeted treatments for stroke. Combination therapies that target the entire neurovascular unit, promote cell survival mechanisms and extend the therapeutic time-window for reperfusion therapy will provide new opportunities to meet the challenges of stroke. Moreover, developing therapies that maintain proper NVU function or prevent age-associated alterations in the NVU may find use in the prevention or treatment of cerebrovascular disease. Thus, the collaborative project will integrate its vast multidisciplinary capacities to generate new hypotheses and conduct exploratory work on microvessel–neuron communication.'
Stroke is a neurovascular disease that occurs when blood flow to the brain is interrupted, resulting in death of brain cells. This leads to a number of debilitating conditions such as paralysis, memory loss and even death.